UfM Chief: Euro-Med Cooperation Is a Necessity, Not Luxury 

Union for the Mediterranean (UfM) Secretary-General Nasser Kamel. Asharq Al-Awsat
Union for the Mediterranean (UfM) Secretary-General Nasser Kamel. Asharq Al-Awsat
TT

UfM Chief: Euro-Med Cooperation Is a Necessity, Not Luxury 

Union for the Mediterranean (UfM) Secretary-General Nasser Kamel. Asharq Al-Awsat
Union for the Mediterranean (UfM) Secretary-General Nasser Kamel. Asharq Al-Awsat

Union for the Mediterranean (UfM) Secretary-General Nasser Kamel confirmed that Euro-Mediterranean cooperation, today more than ever, has become a pressing need, not a luxury.

Speaking about efforts undertaken by the union in 2008, Kamel said they faced many hurdles due to global economic and geopolitical crises, but have seen notable improvement.

“The last three to four years have seen overall relative recovery. First, a number of countries have stabilized and returned to growth. Egypt is a model in this regard, as are Morocco and Jordan,” Kamel said in an interview with Asharq Al-Awsat.

“Today, even Tunisia is stabilizing. Of course, countries such as Libya and Syria still need time, but the geo-strategic situation in general is much better now than in previous years,” he added.

Progress was achieved, according to Kamel, as a result of a strong political will harbored by member states.

The UfM is an intergovernmental organization of 43 member states from Europe and the Mediterranean Basin: 28 EU member states and 15 Mediterranean partner countries from North Africa, Western Asia and Southern Europe.

In the Egyptian capital this week, the UfM organized the first trade forum. The event witnessed the participation of more than 150 representatives of governments, stakeholders, business communities, think tanks and trade interlocutors. Attendees work in regional and international organizations.

On the forum’s sidelines, Kamel told an Asharq Al-Awsat correspondent that the UfM finds a positive model for regional integration in the Gulf Cooperation Council (GCC).

He also underscored the GCC’s resilience against nearby cluster economies and fierce trade wars. Addressing rising populism in a number of European countries, Kamel said it will not affect the union’s work.

“The UfM’s success or decline can act as a thermometer of the regional situation,” Kamel said on the union’s importance.

According to Kamel, the UfM initially suffered because Europe was experiencing an unprecedented financial crunch, especially in South Africa and the world—meanwhile, the Arab world was in a state of extraordinary liquidity. And then geopolitical challenges emerged with Arab Spring protests sweeping the region.

“Therefore, Euro-Mediterranean cooperation faced great challenges,” he said.

“For different reasons, there was no stability in the north or south … each party suffered its own share of acute crises that ranged from mass waves of immigration to armed conflicts, and so forth.”

Speaking on progress in the UfM workframe, Kamel stressed that “Euro-Mediterranean cooperation is not a luxury, and that it is based on an objective rooted in geographic, historic and political realities.”

“Integration between Europe and the southern Mediterranean is geo-strategic. We are separated by a lake, not a sea, but joined by a shared history (with its negative and positive aspects) and brought together in a world governed by the logic of blocs,” Kamel said, arguing that this gives the UfM indispensable value.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.